Because gliclazide lowers postprandial blood glucose, fasting plasma glucose, and glycosolated haemoglobin levels, it is able to regulate our body’s blood sugar levels.
*Products will not be offered for sale in countries where valid Patents are in force.
* It is the responsibility of the buyer to comply with the above.
|API Name :||Gliclazide|
|CAS Number :||21187-98-4|
|Grade :||IP / BP / EP|
|Packing Type :||Drum|
|Therapeutic use :||Insulin Secretagogues|
|Product MOQ :||5 kg|